We demonstrated that, in contrast to classical opioid receptors, ACKR3 does not induce classical G protein signaling and isn't modulated through the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists which include naloxone. Instead, we set up that LIH383, an ACKR3-selective subnanomolar https://hesiodp579vtq0.answerblogs.com/profile